We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Dermasalve | LSE:DRM | London | Ordinary Share | GB0034270156 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 2.75 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
RNS Number : 6392U
Dermasalve Sciences PLC
16 May 2008
DermaSalve Sciences plc
("DermaSalve" or the "Company")
Statement re Share Price Movement
The Directors of DermaSalve note the recent rise in the Company's share price and comments in the press today.
Pursuant to the convertible loan agreement with Trafalgar Capital Specialised Investment Fund ("Trafalgar") announced on 5 October 2007,
a total of 3,263,851 ordinary shares have been issued by the Company to Trafalgar in six separate tranches from 5 October 2007 to 12 March
2008. The Directors understand that Trafalgar has subsequently sold these shares providing a regular supply of new shares into the market.
Trafalgar elected not to convert any portion of the convertible loan in April and the Company made a cash repayment of £23,892. On 15 May
2008 the Company agreed an alternative cash payment plan with Trafalgar which will result in no further shares being issued to Trafalgar for
the foreseeable future.
The Directors are not aware of any other specific reason for the increase in the Company's share price.
Enquiries:
DermaSalve Sciences plc +44 (0)191 260 5070
Dr. Mark Randle, CEO
Phil Pattison, Finance Director
www.dermasalve.com
Hanson Westhouse Limited +44 (0)113 246 2610
Tim Feather / Matthew Johnson
Hansard Group +44 (0)20 7245 1100
Adam Reynolds / Brendan Adams
This information is provided by RNS
The company news service from the London Stock Exchange
END
SPMGUUGGAUPRGUQ
1 Year Dermasalve Sciences Chart |
1 Month Dermasalve Sciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
